Suchergebnisse - "Zhong, Mengya"

PubPharm (47)

1

Application of combined medicine composition in preparation of medicine for preventing or treating T cell lymphoma

enthalten in: Europäisches Patentamt | 2024

von XU BING | LIN JIAQI | ZHA JIE | +4

2

Combined pharmaceutical composition for preventing or treating follicular lymphoma and application thereof

enthalten in: Europäisches Patentamt | 2024

von XU BING | HUANG JIEWEN | ZHA JIE | +4

3

Anlotinib suppresses the DNA damage response by disrupting SETD1A and inducing p53-dependent apoptosis in Transformed Follicular Lymphoma

enthalten in: International journal of medical sciences | 2024

von Zhuang, X. | Yao, J. | Li, X. | +7

4

High-Throughput Drug Screen for Potential Combinations With Venetoclax Guides the Treatment of Transformed Follicular Lymphoma

enthalten in: International journal of toxicology | 2023

von Li, Z. | Pan, G. | Zhong, M. | +4

5

Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling

enthalten in: Journal of cancer research and clinical oncology | 2023

von Pan, G. | Zhong, M. | Yao, J. | +13

6

Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathway

enthalten in: Discover. Oncology | 2023

von Tan, J. | Zhong, M. | Hu, Y. | +15

7

Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathway

enthalten in: Discover oncology | 2023

von Tan, J. | Zhong, M. | Hu, Y. | +15

8

Stratification and therapeutic potential of ELL in cytogenetic normal acute myeloid leukemia

enthalten in: Gene | 2023

von Zha, J. | Zhong, M. | Pan, G. | +7

9

Therapeutic inhibition of PPARα-HIF1α-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemia

enthalten in: Cancer letters | 2023

von Zhou, H. | Jiang, Y. | Huang, Y. | +15

10

Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2022

von Tang, Y. | Zhong, M. | Pan, G. | +11

1
2
3
4
5
Nächster »
[5]